Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioAtla, Inc. (BCAB)

3.55   0.55 (18.33%) 06-26 22:37
Open: 3.15 Pre. Close: 3
High: 3.62 Low: 3.0401
Volume: 2,982,876 Market Cap: 133(M)
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.62 - 3.63 3.63 - 3.64
Low: 3.01 - 3.02 3.02 - 3.04
Close: 3.52 - 3.55 3.55 - 3.57

Technical analysis

as of: 2022-06-24 4:38:18 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.22     One year: 4.93
Support: Support1: 2.66    Support2: 2.07
Resistance: Resistance1: 3.61    Resistance2: 4.22
Pivot: 2.84
Moving Average: MA(5): 2.97     MA(20): 2.75
MA(100): 4.35     MA(250): 19.28
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 76.9     %D(3): 62.2
RSI: RSI(14): 67.9
52-week: High: 44.02  Low: 2
Average Vol(K): 3-Month: 599 (K)  10-Days: 559 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ BCAB ] has closed above the upper band by 16.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 45.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 26 Jun 2022
Britain Cricket England New Zealand | National Sports | elkvalleytimes.com - Elk Valley Times

Sun, 26 Jun 2022
'Biblical' insect swarms spur Oregon push to fight pests - Meridian Star

Sat, 25 Jun 2022
State Liners' 'Mo' Hampton has the major leagues as a goal - Bristol Herald Courier

Sat, 25 Jun 2022
NIL era brought what some expected, others feared - Fairbanks Daily News-Miner

Sat, 25 Jun 2022
Jay M. Phd Short Acquires 29082 Shares of BioAtla, Inc. (NASDAQ:BCAB) Stock - Defense World

Fri, 24 Jun 2022
Millennial Money: 4 items for your midyear money checklist - Citrus County Chronicle

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 35 (M)
% Held by Insiders 2.784e+007 (%)
% Held by Institutions 16.2 (%)
Shares Short 3,580 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -9.511e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -38
Return on Assets (ttm) 576
Return on Equity (ttm) -24.2
Qtrly Rev. Growth 250000
Gross Profit (p.s.) -0.56
Sales Per Share 0
EBITDA (p.s.) -2.5
Qtrly Earnings Growth -2.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -62 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 501.82
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 3.85e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.